JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval
Go back to JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval| AbbVie (NYSE: ABBV) | Delayed: 261.72 +1.73 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.99 | 52 Week High | $68.12 | |||
| Open | $262.70 | 52 Week Low | $50.71 | |||
| Day High | $262.97 | P/E | 56.77 | |||
| Day Low | $257.70 | EPS | $4.61 | |||
| Volume | 4,225,417 | |||||
